http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07278014-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ce3ceb49a54edfbc6b35e9109347c463 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 1994-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1c537da90d40c5ca93b30936a1c719d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb5c658ab20c2285b18128655fadb59f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1425ccc4f1918373ce40bd3640c72c33 |
| publicationDate | 1995-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H07278014-A |
| titleOfInvention | Antihypertensive agent |
| abstract | (57) [Summary] [Structure] An antihypertensive agent containing ulinastatin as an active ingredient. [Effect] Intracellular Ca inflow is suppressed and blood pressure is lowered. Urinastatin, which is used as an active ingredient, is a substance in the body and is a Ca blocker that utilizes or supplements physiological Ca regulation mechanism in the body, so it has fewer side effects and is safer than conventional synthetic Ca blockers. Can be used for |
| priorityDate | 1994-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.